From portfolio optimization to AI implementation. We deliver transformational AI solutions that accelerate exits and maximize returns across your portfolio.
Complex technical and strategic challenges faced by private equity firms in evaluating, implementing, and scaling AI solutions across their portfolios.
Lack of technical expertise to properly evaluate AI/ML capabilities and potential of target companies
Risk of over/under-valuing tech assets by 15-25%, leading to poor investment decisions and missed opportunities
Inability to assess true AI maturity and competitive advantage
Missing critical technical debt and scalability issues
Overestimating revenue projections from AI capabilities
Lack of understanding of data quality and AI model performance
Explore high-growth AI investment opportunities across key sectors with proven ROI potential and clear paths to value creation.
AI-powered diagnostic assistance and treatment recommendations for healthcare providers
AI acceleration of pharmaceutical research and development pipelines
Advanced computer vision for radiology, pathology, and medical diagnostics
AI-driven analytics for large-scale health outcome improvement
Operational optimization and resource allocation in healthcare systems
AI-enabled precision medicine and personalized treatment solutions
Comprehensive AI enablement services designed to accelerate portfolio company transformation and maximize value creation.
Comprehensive AI transformation strategy tailored to your portfolio company's business model
Build enterprise-grade data infrastructure optimized for AI applications across industries
Bespoke AI models and applications for industry-specific workflows and operations
AI-powered operational optimization for enhanced efficiency and performance
AI solutions for regulatory compliance, risk assessment, and quality management
AI-driven financial management, forecasting, and performance optimization
Real portfolio transformations delivering exceptional returns through strategic AI implementation in healthcare companies.
Manual pill-pouch inspection caused errors and throughput bottlenecks in high-volume pharmacy automation equipment.
Deep-learning computer-vision models (Helios & Opticam) integrated into Perata PERL inspectors to verify pill identity, colour, and detect damaged/double pills in real time.
High non-adherence rates among chronic-care patients drove poor outcomes and payer penalties.
PDC-based classification model combining RWD from surveys and pharmacy-dispense data to segment patients by non-adherence risk and trigger targeted interventions.
Rising third-party agency costs and unpredictable survey completions among physician panels.
Gradient-boosted completion-likelihood model with multi-parameter simulation (initial incentive, reminders, delays, step-ups) to minimize campaign spend.
Uncertain claim conversion impaired cash-flow forecasting and prioritisation across a major RCM vendor’s hospital clients.
Dual ML models for inpatient & outpatient claims using admissions, census, mortality and engineered calendar features to score invoicing likelihood.
Disparate imaging data, regulatory complexity, and low patient compliance in a national mammography provider.
Scalable ETL pipelines into a cloud-first enterprise data warehouse, advanced data-modeling, and ML-driven patient-risk stratification for compliance monitoring.
Flexible partnership structures designed to align with your investment strategy and maximize value creation across your healthcare portfolio.
Performance-based partnership where we share in the revenue upside generated by AI/ML transformations for portfolio companies
Strategic equity swaps where Finarb provides AI / Data / GenAI transformations in exchange for minority stakes in portfolio companies
Outcome-guaranteed AI/ML / Data solutions with performance thresholds and success milestoning tied to business KPIs
Shared AI / Data infrastructure & use case development deployed across multiple portfolio companies to maximise scale advantages
Dedicated AI / ML / Data engineering teams embedded into portfolio companies or PE platform offices, on flexible terms
Partnership model where Finarb’s fees + upside are tied to increases in valuation / exit multiples of portfolio companies
Performance-based partnership where we share in the revenue upside generated by AI/ML transformations for portfolio companies
Explore how our AI and data solutions transform other industries
HIPAA-compliant healthcare AI for patient care and clinical decision support.
AI-powered risk assessment, fraud detection, and algorithmic trading solutions.
Comprehensive AI/ML platforms and custom software development solutions.
Find answers to common questions about AI solutions for private equity firms and portfolio companies.
Still have questions? Our private equity AI experts are here to help.
Contact Our TeamJoin leading private equity firms who are accelerating portfolio value creation through strategic AI implementation and digital transformation.